As we have already mentioned, the best care you can take of yourself is via preventive care meaning that you need to monitor the vitals of your body beforehand so that you know exactly what is going on inside your body. People often make the mistake of being careless and taking things for granted until they fall sick and then they get to know the various issues they are having. This is where Neko Health founded by Spotify CEO is taking action and building a company that is focused on preventive healthcare rather than reactive healthcare.
Neko Health CEO Hjalmar Nilsonne noted in a statement, “Healthcare costs are spiraling out of control — we believe preventive health will be key to reversing this trend”. “Doctors today just don’t have enough time or resources to focus on prevention. This leads to many health problems going unnoticed until they get really serious, causing a lot of pain and putting a massive strain on the healthcare system.”
Neko Health has just announced raising $65M in a Series A round of funding and the company is built “with the lofty promise of preventative healthcare via full-body scans backed by AI software that help doctors detect skin conditions including cancer, cardiovascular disease and diabetes, among other metabolic syndromes”. For those who are unaware, Neko Health is the same startup that was founded by Spotify CEO Daniel Ek and we know that it was not tough for them to raise funding since he is already deep inside the industry. Talking about Neko Health, the company says that “Each scan apparently takes around 10 minutes and costs €250” and this is followed by an in-person visit where the results of your scan are explained and you will get to know the steps you need to take further.
There are, however, some concerns right now regarding Neko Health as well. Particularly regarding the fact that Neko Health has been very secretive about exactly what it does right now and how it plans to provide full-body scans. The company has not even allowed the press to question them during the launch of their company and neither during their Series A funding announcement.